CROs are Contract Research Organizations that provide support to companies for their research services as outsourced contract based.

As mentioned in the lecture, the sponsor usually transfers one or more of his/her responsibilities to these CROs. Out of the responsibilities that Dr. Simon listed, which ones would a good sponsor never transfer over to a CRO? In other words, what are the advantages and disadvantages of transferring responsibilities to Clinical Research Organizations?